India is looking forward to the WHO’s approval for its indigenous Covid-19 vaccine manufactured by Bharat Biotech and is in talks with major vaccine manufacturers like Pfizer, Johnson & Johnson, and Moderna about sourcing and possible local manufacture of their jabs in India, Foreign Secretary Harsh Vardhan Shringla said today.
Hyderabad-based Bharat Biotech has applied to the WTO for the Emergency Use Listing (EUL) of its vaccine candidate Covaxin. However, the WHO has sought “more information” from Bharat Biotech on its EUL application.
Addressing the WHO’s “South-East Asia Regional Health Partners’ Forum on Covid-19”, Shringla also stated that India was working with several other countries in the WTO on a targeted and temporary waiver under TRIPS to ensure timely and secure access to vaccines for all.
